Education
About Us
Working with TipRanks
Follow Us
BeiGene Ltd (HK:6160)
:6160
Comparison Results
Innovent Biologics
HK$81.80
HK$143.26B
110.12
133.38%
13 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$33.14
$141.02B
29.73
90.68%
4 Buy
1 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$103.80
HK$299.18B
18.57
86.43%
13 Buy
1 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.50
HK$233.12B
44.35
117.93%
6 Buy
1 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$70.55
HK$444.64B
60.70
26.84%
4 Buy
1 Hold
1 Sell
Moderate Buy
Performance Comparison
HK:6160
BeiGene Ltd
186.60
80.50
75.87%
HK:1801
Innovent Biologics
81.80
46.75
133.38%
HK:2269
Wuxi Biologics (Cayman)
33.14
15.76
90.68%
HK:2359
WuXi AppTec Co., Ltd. Class H
101.10
46.87
86.43%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.40
20.78
117.93%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
70.55
16.85
31.38%